BamSEC and AlphaSense Join Forces
Learn More

Rocket Pharmaceuticals Inc.

NASDAQ: RCKT    
Share price (12/27/24): $11.75    
Market cap (12/27/24): $1.071 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment of Seventh Amended and Restated Certificate of Incorporation of Rocket Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 10-Q 1 page Certifications
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Seventh Amended and Restated Certificate of Incorporation of Rocket Pharmaceuticals, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 17 pages Amended and Restated By-Laws of Rocket Pharmaceuticals, Inc
12/34/56
EX-3.4
from 8-A12B/A 15 pages Amended and Restated By-Laws of Rocket Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment of Seventh Amended and Restated Certificate of Incorporation of Inotek Pharmaceuticals Corporation Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Seventh Amended and Restated Certificate of Incorporation of Inotek Pharmaceuticals Corporation Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 10-K 22 pages Amended and Restated By-Laws of Inotek Pharmaceuticals Corporation
12/34/56
EX-3.1
from 10-K 7 pages Seventh Amended and Restated Certificate of Incorporation of Inotek Pharmaceuticals Corporation
12/34/56
EX-3.1
from S-1/A 36 pages Fifth Amended and Restated Certificate of Incorporation of Inotek Pharmaceuticals Corporation
12/34/56
EX-3.2
from S-1/A 8 pages Seventh Amended and Restated Certificate of Incorporation of Inotek Pharmaceuticals Corporation
12/34/56
EX-3.1
from S-1/A 33 pages Fifth Amended and Restated Certificate of Incorporation of Inotek Pharmaceuticals Corporation
12/34/56
EX-3.4
from S-1/A 22 pages Amended and Restated By-Laws of Inotek Pharmaceuticals Corporation
12/34/56
EX-3.3.4
from S-1 2 pages Amendment No. 3 to By-Laws of Inotek Pharmaceuticals Corporation Dated August 21, 2007 [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3.3.3
from S-1 2 pages Amendment No. 2 to By-Laws of Inotek Pharmaceuticals Corporation Dated August 15, 2005
12/34/56
EX-3.3.2
from S-1 2 pages Amendment No. 1 to By-Laws of Inotek Pharmaceuticals Corporation Dated February 12, 2004 [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3.3.1
from S-1 14 pages Inotek Corporation By-Laws
12/34/56
EX-3
from DRS 2 pages Amendment No. 3 to By-Laws of Inotek Pharmaceuticals Corporation Dated August 21, 2007 [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3
from DRS 2 pages Amendment No. 2 to By-Laws of Inotek Pharmaceuticals Corporation Dated August 15, 2005
12/34/56
EX-3
from DRS 2 pages Amendment No. 1 to By-Laws of Inotek Pharmaceuticals Corporation Dated February 12, 2004 [Remainder of Page Intentionally Left Blank]
12/34/56